Abstract | BACKGROUND: Antiretroviral therapy (ART) reduces transmission of HIV-1. However, genital HIV-1 can be detected in patients on ART. We analyzed factors associated with genital HIV-1 shedding among high-risk women on ART in Burkina Faso. METHODS: Plasma viral load (PVL) and enriched cervicovaginal lavage HIV-1 RNA were measured every 3-6 months for up to 8 years. Random-effects logistic and linear regression models were used to analyze associations of frequency and quantity of genital HIV-1 RNA with behavioral and biological factors, adjusting for within-woman correlation. The lower limit of detection of HIV-1 RNA in plasma and eCVL samples was 300 copies per milliliter. RESULTS: One hundred and eighty-eight participants initiated ART from 2004 to 2011. PVL was detectable in 16% (171/1050) of visits, in 52% (90/174) of women. Cervicovaginal HIV-1 RNA was detectable in 16% (128/798) of visits with undetectable plasma HIV-1 RNA in 45% (77/170) of women. After adjusting for PVL, detectable cervicovaginal HIV-1 RNA was independently associated with abnormal vaginal discharge and use of nevirapine or zidovudine vs. efavirenz and stavudine, respectively; longer time on ART and hormonal contraception were not associated with increased shedding. The presence of bacterial vaginosis, herpes simplex virus-2 DNA, and the use of nevirapine vs efavirenz were independently associated with an increased quantity of cervicovaginal HIV-1 RNA. CONCLUSIONS:
|
Authors | Andrea J Low, Issouf Konate, Nicolas Nagot, Helen A Weiss, Dramane Kania, Peter Vickerman, Michel Segondy, David Mabey, Deenan Pillay, Nicolas Meda, Philippe van de Perre, Philippe Mayaud, Yerelon Study Group |
Journal | Journal of acquired immune deficiency syndromes (1999)
(J Acquir Immune Defic Syndr)
Vol. 65
Issue 2
Pg. 237-45
(Feb 01 2014)
ISSN: 1944-7884 [Electronic] United States |
PMID | 24226060
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Adolescent
- Adult
- Antiretroviral Therapy, Highly Active
(methods)
- Burkina Faso
- Cohort Studies
- Female
- Genitalia, Female
(virology)
- HIV Infections
(drug therapy, virology)
- HIV-1
(isolation & purification)
- Humans
- Longitudinal Studies
- Male
- Middle Aged
- Plasma
(virology)
- RNA, Viral
(blood, isolation & purification)
- Risk Factors
- Viral Load
- Virus Shedding
- Young Adult
|